J.P. Morgan reduces its stake in SINOPHARM (01099) by approximately 1.22 million shares, with a price of around HK$19.87 per share.
On February 18, J.P. Morgan reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,221,708 shares, with each share priced at HK$19.8733.
According to the latest data from the Hong Kong Stock Exchange, on February 18th, J.P. Morgan reduced its holdings of SINOPHARM (01099) by 1,221,708 shares, with an average price of HK$19.8733 per share, for a total amount of approximately HK$24.2794 million. After the reduction, the latest number of shares held is approximately 107 million shares, and the latest shareholding ratio is 7.96%.
Related Articles

New stock news | The offering of Cig Shanghai (06166) has ended with a total subscription of 107.4 billion Hong Kong dollars, oversubscribed by 232 times.

New stock news | Eight Horses Tea (06980) ends its IPO. The total subscription amount reached HKD 8.53 billion, 1896 times oversubscribed.
.png)
HK Stock Market Move | IDREAMSKY (01119) Increased by nearly 7% in the afternoon, Karapitchou mobile game launched a full platform public beta, ranking TOP1 on the free list of the App Store.
New stock news | The offering of Cig Shanghai (06166) has ended with a total subscription of 107.4 billion Hong Kong dollars, oversubscribed by 232 times.

New stock news | Eight Horses Tea (06980) ends its IPO. The total subscription amount reached HKD 8.53 billion, 1896 times oversubscribed.

HK Stock Market Move | IDREAMSKY (01119) Increased by nearly 7% in the afternoon, Karapitchou mobile game launched a full platform public beta, ranking TOP1 on the free list of the App Store.
.png)
RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025